Atlas Trials

Autolus Limited

11 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Autolus Limited

RecordFirmDate
Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN) (NCT07053800)Autolus Limited2026-01-16
Obe-cel in Refractory Progressive Forms of Multiple Sclerosis (NCT07139743)Autolus Limited2025-08-04
Obe-cel in Adolescent [Applicable in UK Only] and Adult Severe, Refractory Systemic Lupus Erythematosus (NCT06333483)Autolus Limited2024-02-02
A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL) (NCT06173518)Autolus Limited2023-11-16
A Study of CD19 Targeted CAR T Cell Therapy in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL) (NCT04404660)Autolus Limited2020-06-03
Phase I/II Study Evaluating AUTO4 in Patients With T Cell Receptor Beta Constant (TRBC)1 Positive T Cell Lymphoma (NCT03590574)Autolus Limited2018-08-30
Long-term Follow-up of Patients Treated With Genetically Modified Autologous T Cells (NCT03628612)Autolus Limited2018-08-02
Cluster of Differentiation Antigen 19/22(CD19/22) CAR T Cells (AUTO3) for the Treatment of Diffuse Large B Cell Lymphoma (NCT03287817)Autolus Limited2017-09-05

Track Autolus Limited automatically

Every clearance here is in the API, with alerts when new ones post.